| 
																	
																	
																		 Connection
 
																		  Anne  Fuhlbrigge  to  Severity of Illness Index 
																		
																	 
																		 This is a "connection" page, showing publications  Anne  Fuhlbrigge  has written about  Severity of Illness Index.  
																		
																	 
																			
																					
	
						
				
		
			
			
			|  | 
				
					|  | Connection Strength |  |  
					|  |   |  |  
					|  | 1.002 |  |  |  |  
		
		
			
				Fuhlbrigge A, Peden D, Apter AJ, Boushey HA, Camargo CA, Gern J, Heymann PW, Martinez FD, Mauger D, Teague WG, Blaisdell C. Asthma outcomes: exacerbations. J Allergy Clin Immunol. 2012 Mar; 129(3 Suppl):S34-48.	
				
				
					Score: 0.213
				
				Fuhlbrigge AL, Weiss ST, Kuntz KM, Paltiel AD. Forced expiratory volume in 1 second percentage improves the classification of severity among children with asthma. Pediatrics. 2006 Aug; 118(2):e347-55.	
				
				
					Score: 0.145
				
				Fuhlbrigge AL. Asthma severity and asthma control: symptoms, pulmonary function, and inflammatory markers. Curr Opin Pulm Med. 2004 Jan; 10(1):1-6.	
				
				
					Score: 0.121
				
				Sullivan PW, Ghushchyan VH, Marvel J, Barrett YC, Fuhlbrigge AL. Association Between Pulmonary Function and Asthma Symptoms. J Allergy Clin Immunol Pract. 2019 Sep - Oct; 7(7):2319-2325.	
				
				
					Score: 0.088
				
				Fuhlbrigge AL, Bengtsson T, Peterson S, Jauhiainen A, Eriksson G, Da Silva CA, Johnson A, Sethi T, Locantore N, Tal-Singer R, Fager?s M. A novel endpoint for exacerbations in asthma to accelerate clinical development: a post-hoc analysis of randomised controlled trials. Lancet Respir Med. 2017 07; 5(7):577-590.	
				
				
					Score: 0.077
				
				Lane SJ, Petersen H, Seltzer JM, Blanchette CM, Navaratnam P, Allen-Ramey F, Fuhlbrigge A. Moderate symptom-based exacerbations as predictors of severe claims-based exacerbations in asthma. J Asthma. 2013 Aug; 50(6):642-8.	
				
				
					Score: 0.058
				
				Greenberg S, Liu N, Kaur A, Lakshminarayanan M, Zhou Y, Nelsen L, Gates DF, Kuo WL, Smugar SS, Reiss TF, Barnes N, Fuhlbrigge A, Milgrom H, Schatz M, Knorr B. The asthma disease activity score: a discriminating, responsive measure predicts future asthma attacks. J Allergy Clin Immunol. 2012 Nov; 130(5):1071-1077.e10.	
				
				
					Score: 0.056
				
				Cooke CE, Sidel M, Belletti DA, Fuhlbrigge AL. Review: clinical inertia in the management of chronic obstructive pulmonary disease. COPD. 2012 Feb; 9(1):73-80.	
				
				
					Score: 0.053
				
				Wu AC, Paltiel AD, Kuntz KM, Weiss ST, Fuhlbrigge AL. Cost-effectiveness of omalizumab in adults with severe asthma: results from the Asthma Policy Model. J Allergy Clin Immunol. 2007 Nov; 120(5):1146-52.	
				
				
					Score: 0.039
				
				Fuhlbrigge AL, Guilbert T, Spahn J, Peden D, Davis K. The influence of variation in type and pattern of symptoms on assessment in pediatric asthma. Pediatrics. 2006 Aug; 118(2):619-25.	
				
				
					Score: 0.036
				
				Vogelmeier CF, Fuhlbrigge A, Jauhiainen A, Scheepers LEJM, Bengtsson T, Peterson S, Karlsson N, Sethi T, Locantore N, Tal-Singer R, Rennard S, Fager?s M, Da Silva CA. COPDCompEx: A novel composite endpoint for COPD exacerbations to enable faster clinical development. Respir Med. 2020 11; 173:106175.	
				
				
					Score: 0.024
				
				Kim WJ, Yim JJ, Kim DK, Lee MG, Fuhlbrigge AL, Sliwinski P, Hawrylkiewicz I, Wan ES, Cho MH, Silverman EK. Severe COPD cases from Korea, Poland, and USA have substantial differences in respiratory symptoms and other respiratory illnesses. Int J Chron Obstruct Pulmon Dis. 2017; 12:3415-3423.	
				
				
					Score: 0.020
				
				Wu AC, Tantisira K, Li L, Fuhlbrigge AL, Weiss ST, Litonjua A. Effect of vitamin D and inhaled corticosteroid treatment on lung function in children. Am J Respir Crit Care Med. 2012 Sep 15; 186(6):508-13.	
				
				
					Score: 0.014
				
				Wu AC, Tantisira K, Li L, Schuemann B, Weiss ST, Fuhlbrigge AL. Predictors of symptoms are different from predictors of severe exacerbations from asthma in children. Chest. 2011 Jul; 140(1):100-107.	
				
				
					Score: 0.012
				
				Tantisira KG, Silverman ES, Mariani TJ, Xu J, Richter BG, Klanderman BJ, Litonjua AA, Lazarus R, Rosenwasser LJ, Fuhlbrigge AL, Weiss ST. FCER2: a pharmacogenetic basis for severe exacerbations in children with asthma. J Allergy Clin Immunol. 2007 Dec; 120(6):1285-91.	
				
				
					Score: 0.010
				
				Bender BG, Fuhlbrigge A, Walders N, Zhang L. Overweight, race, and psychological distress in children in the Childhood Asthma Management Program. Pediatrics. 2007 Oct; 120(4):805-13.	
				
				
					Score: 0.010
				
				Adams RJ, Fuhlbrigge A, Guilbert T, Lozano P, Martinez F. Inadequate use of asthma medication in the United States: results of the asthma in America national population survey. J Allergy Clin Immunol. 2002 Jul; 110(1):58-64.	
				
				
					Score: 0.007
				
				Finkelstein JA, Fuhlbrigge A, Lozano P, Grant EN, Shulruff R, Arduino KE, Weiss KB. Parent-reported environmental exposures and environmental control measures for children with asthma. Arch Pediatr Adolesc Med. 2002 Mar; 156(3):258-64.	
				
				
					Score: 0.007
				
				Kuntz KM, Kitch BT, Fuhlbrigge AL, Paltiel AD, Weiss ST. A novel approach to defining the relationship between lung function and symptom status in asthma. J Clin Epidemiol. 2002 Jan; 55(1):11-8.	
				
				
					Score: 0.007
				
				Adams RJ, Fuhlbrigge A, Finkelstein JA, Lozano P, Livingston JM, Weiss KB, Weiss ST. Use of inhaled anti-inflammatory medication in children with asthma in managed care settings. Arch Pediatr Adolesc Med. 2001 Apr; 155(4):501-7.	
				
				
					Score: 0.006
				 | 
																	
																		
																			
																					    Connection Strength   
  The connection strength for concepts is the sum of the scores for each matching publication.  
 Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
 |